NKTX Nkarta Inc
Price (delayed)
$1.91
Market cap
$135.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.6
Enterprise value
$185.19M
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with
Highlights
NKTX's EPS is up by 33% year-on-year and by 15% since the previous quarter
NKTX's quick ratio is up by 33% year-on-year and by 12% since the previous quarter
Nkarta's equity has increased by 49% YoY but it has decreased by 5% QoQ
Key stats
What are the main financial stats of NKTX
Market
Valuations
Earnings
Shares outstanding
70.96M
Market cap
$135.53M
Enterprise value
$185.19M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.33
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$128.19M
Net income
-$108.79M
EBIT
-$108.79M
EBITDA
-$97.35M
Free cash flow
-$104.11M
Per share
Balance sheet
Liquidity
EPS
-$1.6
EPS diluted
-$1.6
Free cash flow per share
-$1.53
Book value per share
$5.78
Revenue per share
$0
TBVPS
$7.39
Total assets
$501.2M
Total liabilities
$93.23M
Debt
$80.27M
Equity
$407.98M
Working capital
$254.42M
Debt to equity
0.2
Current ratio
14.45
Quick ratio
14.28
Net debt/EBITDA
-0.51
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-20.1%
Return on equity
-24.6%
Return on invested capital
-22.3%
Return on capital employed
-22.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NKTX stock price
How has the Nkarta stock price performed over time
Intraday
3.52%
1 week
39.42%
1 month
9.14%
1 year
-80.69%
YTD
-23.29%
QTD
3.8%
Financial performance
How have Nkarta's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$128.19M
Net income
-$108.79M
Gross margin
N/A
Net margin
N/A
Nkarta's net income has increased by 7% YoY
Nkarta's operating income has increased by 2.6% YoY
Growth
What is Nkarta's growth rate over time
Valuation
What is Nkarta stock price valuation
P/E
N/A
P/B
0.33
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NKTX's EPS is up by 33% year-on-year and by 15% since the previous quarter
The P/B is 82% below the 5-year quarterly average of 1.8 and 60% below the last 4 quarters average of 0.8
Nkarta's equity has increased by 49% YoY but it has decreased by 5% QoQ
Efficiency
How efficient is Nkarta business performance
NKTX's return on equity is up by 35% year-on-year and by 9% since the previous quarter
The ROA has grown by 28% YoY and by 7% from the previous quarter
NKTX's return on invested capital is up by 16% year-on-year and by 8% since the previous quarter
Dividends
What is NKTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NKTX.
Financial health
How did Nkarta financials performed over time
NKTX's quick ratio is up by 33% year-on-year and by 12% since the previous quarter
The current ratio has grown by 33% YoY and by 12% from the previous quarter
NKTX's debt is 80% smaller than its equity
Nkarta's equity has increased by 49% YoY but it has decreased by 5% QoQ
NKTX's debt to equity is down by 38% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.